Ocular surface disease in glaucoma patients: Expert opinion and management algorithm in Algeria

被引:0
|
作者
Lazreg, Sihem [1 ]
Garout, Rachid
Boulanab, Fouzia [2 ]
Aberkane, Djalil [3 ]
Djabour, Mustapha [4 ]
Boudedja, Hakim [5 ]
Acheli, Asma [6 ]
Derdour, Amine [7 ]
El Abidine, Nairouz Zine [8 ]
Ghemri, Nadia [9 ]
机构
[1] Cabinet Prive Ophtalmol, Blida, Algeria
[2] CHU Ibn Rochd, Serv Ophtalmol, Annaba, Algeria
[3] Clin El Azhar, Algiers, Algeria
[4] CHU Mohamed Lamine Debaghine, Serv Ophtalmol, Algiers, Algeria
[5] CHU Nafissa Hamoud, Serv Ophtalmol, Algiers, Algeria
[6] CHU Mustapha Pacha, Serv Ophtalmol, Algiers, Algeria
[7] EHS Hammou Boutlelis, Serv Ophtalmol, Oran, Algeria
[8] Clin Ophtalmol Abou Bacer, Algiers, Algeria
[9] CHU Issad Hassani, Serv Ophtalmol, Algiers, Algeria
来源
JOURNAL FRANCAIS D OPHTALMOLOGIE | 2023年 / 46卷 / 02期
关键词
Glaucoma; Ocular surface; Medication; Toxicity; Preservative; Screening; QUALITY-OF-LIFE; DRY EYE; ANTIGLAUCOMA MEDICATIONS; PREVALENCE; SYMPTOMS; PRESERVATIVES; SIGNS; ADHERENCE; THERAPY;
D O I
10.1016/j.jfo.2022.07.025
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Introduction. - The main goal of treatment for any glaucoma patient is to reduce the intrao-cular pressure. Unfortunately, the long-term use of glaucoma medications causes deleterious effects on the ocular surface, leading to impaired quality of life and failed glaucoma surgery. In addition, adverse effects of medications are a barrier to adherence and compliance, and this directly affects efficacy. It is therefore essential to regularly assess the ocular surface of glaucoma patients in order to detect any signs of damage early and act accordingly. Although the TFOS DEWS 2 now offers a strategy for diagnosing ocular surface pathologies, some exami-nations are unfortunately not feasible in Algeria due to lack of time and/or knowledge on the part of some ophthalmologists or are simply inaccessible to others.Methods. - Algerian experts (members of the ACOS club) met for the purpose of proposing an algorithm for the management of Algerian glaucoma patients, based on the recommen-dations of the DEWS, their own practice and the results of a preliminary national survey of ophthalmologists.Results. - The proposed algorithm allows evaluation of the ocular surface of the glaucoma patient in current practice by any Algerian ophthalmologist.Conclusion. - Management of glaucoma patients should include a systematic examination of the ocular surface. The choice of treatment should be determined by the ocular surface condition of the glaucoma patient.(c) 2023 The Authors. Published by Elsevier Masson SAS. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:152 / 162
页数:11
相关论文
共 50 条
  • [41] EXPERT OPINION ON THE MANAGEMENT OF CLN2 DISEASE
    Williams, Ruth E.
    Cohen-Pfeffer, Jessica
    Adams, Heather
    Blohm, Martin
    de los Reyes, Emily
    Denecke, Jonas
    Drago, Kristen
    Fairhurst, Charlie
    Frazier, Margie
    Guelbert, Norberto
    Kiss, Szilard
    Kofler, Annamaria
    Lawson, John
    Lehwald, Lenora
    Leung, Mary-Anne
    Mikhailova, Svetlana
    Mink, Jonathan
    Nickel, Miriam
    Shediac, Renee
    Sims, Katherine
    Specchio, Nicola
    Topcu, Meral
    von Lobbecke, Ina
    West, Andrea
    Schulz, Angela
    MOLECULAR GENETICS AND METABOLISM, 2016, 117 (03) : 293 - 293
  • [42] Expert opinion on the management of CLN2 disease
    Schulz, Angela
    Adams, Heather R.
    Blohm, Martin
    Cohen-Pfeffer, Jessica L.
    de los Reyes, Emily
    Denecke, Jonas
    Drago, Kristen
    Fairhurst, Charlie
    Frazier, Margie
    Guelbert, Norberto
    Kiss, Szilard
    Kofler, Annamaria
    Lawson, John
    Lehwald, Lenora
    Leung, Mary-Anne
    Mikhailova, Svetlana
    Mink, Jonathan W.
    Nickel, Miriam
    Shediac, Renee
    Sims, Katherine
    Specchio, Nicola
    Topcu, Meral
    von Loebbecke, Ina
    West, Andrea
    Williams, Ruth E.
    MOLECULAR GENETICS AND METABOLISM, 2016, 117 (02) : S103 - S104
  • [43] Ustekinumab in the management of Crohn's disease: Expert opinion
    Armuzzi, Alessandro
    Ardizzone, Sandro
    Biancone, Livia
    Castiglione, Fabiana
    Danese, Silvio
    Gionchetti, Paolo
    Orlando, Ambrogio
    Rizzello, Fernando
    Scribano, Maria Lia
    Vecchi, Maurizio
    Daperno, Marco
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (07) : 653 - 660
  • [44] Combined Baerveldt tube implant and keratolimbal allograft for the management of glaucoma and ocular surface disease
    Sinclair, JM
    Lushine, MJ
    Holland, EJ
    Wright, MM
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S274 - S274
  • [45] Impact of glaucoma medications and ocular surface disease on the quality of life of glaucoma patients in the district of Sousse (Tunisia)
    Leila, K.
    Gatfaoui, F.
    Mahjoub, A.
    Yakoubi, S.
    Krifa, F.
    Ghorbel, M.
    Mahjoub, H.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2019, 42 (05): : 464 - 470
  • [46] The management of ocular surface disease
    Elder, MJ
    Bernauer, W
    Dart, JKG
    CICATRISING CONJUNCTIVITIS, 1997, 28 : 219 - 227
  • [47] Ocular Surface Disease and Glaucoma Medications: A Clinical Approach
    Zhang, Xuemin
    Vadoothker, Saujanya
    Munir, Wuqaas M.
    Saeedi, Osamah
    EYE & CONTACT LENS-SCIENCE AND CLINICAL PRACTICE, 2019, 45 (01): : 11 - 18
  • [48] Ocular Surface Disease in Glaucoma: Effect of Polypharmacy and Preservatives
    Ramli, Norlina
    Supramaniam, Gowri
    Samsudin, Amir
    Juana, Azida
    Zahari, Mimiwati
    Choo, May May
    OPTOMETRY AND VISION SCIENCE, 2015, 92 (09) : E222 - E226
  • [49] Incidence and prevalence of glaucoma in severe ocular surface disease
    Tsai, Julie H.
    Derby, Elizabeth
    Holland, Edward J.
    Khatana, Anup K.
    CORNEA, 2006, 25 (05) : 530 - 532
  • [50] Severe ocular surface disease and glaucoma in a newborn with aniridia
    Al-Shahwan, S
    Edward, DP
    Khan, AO
    JOURNAL OF AAPOS, 2005, 9 (05): : 499 - 500